![John Markels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Markels
Director/Board Member at
SANGAMO THERAPEUTICS, INC.
Net worth: 5 211 $ as of 2026-07-30
Profile
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. since 2020.
He is a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. He has been an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
He is an Independent Director at Vaxcyte, Inc. starting in 2026.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 71,384 ( 0.02% ) | 5 211 $ | 2026-07-30 | |
| 2026-06-04 | 0 ( -.--% ) | - $ | 2026-07-30 |
John Markels active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 2020-02-10 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 2022-12-07 |
| VAXCYTE, INC. | Director/Board Member | 2026-07-15 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Former positions of John Markels
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 2022-02-28 |
Training of John Markels
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- John Markels
